evaluation findings - is pre/post sufficient?

Pre/post evaluation designs of asthma interventions are weak since absent any intevention, utilization decreases over time due to regression to mean. Convincing (at least to researchers) studies require a control group. Are the pre/post data sufficient to convince plans, medicaid officials, etc. of the value proposition?

Views expressed on do not necessarily reflect EPA or MCAN policy or guidance. Read full disclaimer »